Literature DB >> 20122680

Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio.

Imran Bhatti1, Oliver Peacock, Gareth Lloyd, Michael Larvin, Richard I Hall.   

Abstract

BACKGROUND: The objective of this study was to investigate whether the preoperative hematologic markers, the platelet-lymphocyte ratio (PLR), or the neutrophil-lymphocyte ratio (NLR) ratio are significant prognostic indicators in resected pancreatic ductal adenocarcinoma.
METHODS: A total of 84 patients undergoing pancreatoduodenectomy for pancreatic ductal adenocarcinoma over a 10-year period were identified from a retrospectively maintained database.
RESULTS: The preoperative NLR was found to be a significant prognostic marker (P = .023), whereas PLR had no significant relationship with survival (P = .642) using univariate Cox survival analysis. The median overall survival in patients with an NLR of < or =3.0 (n = 55) was 13.7, 17.0 months in those with an NLR of 3.0 to 4.0 (n = 17) and 5.9 months in patients with a value of >4.0 (n = 12) (log rank, P = .016). The NLR retained its significance on multivariate analysis (P = .039) along with resection margin status (P = .001).
CONCLUSION: The preoperative NLR represents a significant independent prognostic indicator in patients with resected pancreatic ductal adenocarcinoma, whereas PLR does not. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122680     DOI: 10.1016/j.amjsurg.2009.08.041

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  131 in total

1.  Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.

Authors:  Joonho Jung; Seong Yong Park; Soo-Jin Park; Jiye Park
Journal:  Tumour Biol       Date:  2015-12-12

2.  Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer.

Authors:  Mehmet Kos; Cemil Hocazade; F Tugba Kos; Dogan Uncu; Esra Karakas; Mutlu Dogan; Hikmet Gulsen Uncu; Nuriye Yildirim; Nurullah Zengin
Journal:  Wien Klin Wochenschr       Date:  2015-02-27       Impact factor: 1.704

3.  Preoperative Nutritional Assessment Using the Controlling Nutritional Status Score to Predict Pancreatic Fistula After Pancreaticoduodenectomy.

Authors:  Masashi Utsumi; Hideki Aoki; Seichi Nagahisa; Seitaro Nishimura; Yuta Une; Yuji Kimura; Fumitaka Taniguchi; Takashi Arata; Koh Katsuda; Kohji Tanakaya
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

4.  Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer.

Authors:  Hongbing Liu; Ying Wu; Zhaofeng Wang; Yanwen Yao; Fangfang Chen; He Zhang; Yunfen Wang; Yong Song
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 5.  Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis.

Authors:  Matteo Cescon; Valentina Rosa Bertuzzo; Giorgio Ercolani; Matteo Ravaioli; Federica Odaldi; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

6.  Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma.

Authors:  G Garcea; N Ladwa; C P Neal; M S Metcalfe; A R Dennison; D P Berry
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

7.  The relationship of platelet to lymphocyte ratio and neutrophil to monocyte ratio to radiographic grades of knee osteoarthritis.

Authors:  J Shi; W Zhao; H Ying; J Du; J Chen; S Chen; B Shen
Journal:  Z Rheumatol       Date:  2018-08       Impact factor: 1.372

8.  Neutrophil-to-lymphocyte ratio as a prognostic factor for pharyngocutaneous fistula after total laryngectomy.

Authors:  F T Aires; R A Dedivitis; M A V Kulcsar; D M Ramos; C R Cernea
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-02       Impact factor: 2.124

9.  Prognostic Scoring System for Patients Who Present with a Gastric Outlet Obstruction Caused by Advanced Pancreatic Adenocarcinoma.

Authors:  Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Yusuke Yamamoto; Ryo Ashida; Yukio Yoshida; Masaki Tanaka; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

10.  Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.

Authors:  Aaron J Schueneman; Elizabeth A Sugar; Jennifer Uram; Elaine Bigelow; Joseph M Herman; Barish H Edil; Elizabeth M Jaffee; Lei Zheng; Daniel A Laheru
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.